1. Home
  2. CDXS vs BWG Comparison

CDXS vs BWG Comparison

Compare CDXS & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Codexis Inc.

CDXS

Codexis Inc.

N/A

Current Price

$1.19

Market Cap

154.4M

Sector

Industrials

ML Signal

N/A

Logo BrandywineGLOBAL Global Income Opportunities Fund Inc.

BWG

BrandywineGLOBAL Global Income Opportunities Fund Inc.

N/A

Current Price

$6.82

Market Cap

134.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CDXS
BWG
Founded
2002
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Finance/Investors Services
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
154.4M
134.7M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CDXS
BWG
Price
$1.19
$6.82
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $6.14
N/A
AVG Volume (30 Days)
★ 813.0K
110.1K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 11.37%
EPS Growth
★ 43.82
N/A
EPS
N/A
★ N/A
Revenue
★ $138,590,000.00
N/A
Revenue This Year
$4.97
N/A
Revenue Next Year
$18.69
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 32.30
N/A
52 Week Low
$0.96
$6.69
52 Week High
$2.98
$8.68

Technical Indicators

Market Signals
Indicator
CDXS
BWG
Relative Strength Index (RSI) 37.73 35.76
Support Level $1.12 $6.76
Resistance Level $1.24 $7.05
Average True Range (ATR) 0.08 0.09
MACD -0.00 0.00
Stochastic Oscillator 6.52 30.27

Price Performance

Historical Comparison
CDXS
BWG

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.

BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.

Share on Social Networks: